Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hegazy M. Hegazy"'
Autor:
Wagih A. El-Shouny, Sameh S. Ali, Hegazy M. Hegazy, Manar K. Abd Elnabi, Asmaa Ali, Jianzhong Sun
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 10, Iss 4, Pp 366-377 (2020)
The Pan-Drug Resistant (PDR), Helicobacter pylori remains an intractable challenge in public health worldwide and this pathogenicity is mainly due to the presence of a cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA). On the othe
Externí odkaz:
https://doaj.org/article/5b606f25dc5a4e909feb0bf0e6da4b10
Publikováno v:
Egyptian Liver Journal, Vol 11, Iss 1, Pp 1-9 (2021)
Background Despite the great advancement in therapeutic modalities for esophageal varices, early variceal rebleeding still occurs at high rates leading to an exaggeration of the morbidity and mortality for cirrhotic patients, so meticulous follow-up
Autor:
Manar K. Abd Elnabi, Hegazy M. Hegazy, Asmaa Ali, Jianzhong Sun, Wagih El-Shouny, Sameh S. Ali
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 10, Iss 4, Pp 366-377 (2020)
Journal of Traditional and Complementary Medicine
Journal of Traditional and Complementary Medicine
The Pan-Drug Resistant (PDR), Helicobacter pylori remains an intractable challenge in public health worldwide and this pathogenicity is mainly due to the presence of a cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA). On the othe
Publikováno v:
The Medical Journal of Cairo University. 87:3597-3605
Background: Diabetes mellitus has been reported to increase the risk of complications of liver cirrhosis and subsequent survival. Varices constitute the most common lethal cause of mortality in cirrhotic patients, consequently the association between
Autor:
Maha A. F. Khalil, Emad M. S. Elfeky, Abd El-Raheem R. El-Shanshoury, Mohammed Ali Ahmed Eid, Wagih A. El Shouny, Hegazy M. Hegazy
Publikováno v:
THE EGYPTIAN JOURNAL OF EXPERIMENTAL BIOLOGY (Botany). :67
The present study aimed to evaluate the impact of the long-term treatment with a combination of Spirulina platensis (Sp), Ganoderma lucidum (Gd), silymarin (Sil), and green tea (Gt) in HCV patients. Forty-five adult males (M) and females (F) HCV pati